339 related articles for article (PubMed ID: 26409322)
21. Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells.
McCarthy-Keith DM; Malik M; Britten J; Segars J; Catherino WH
Fertil Steril; 2011 Jun; 95(7):2383-7. PubMed ID: 21496801
[TBL] [Abstract][Full Text] [Related]
22. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment.
Ito F; Kawamura N; Ichimura T; Tsujimura A; Ishiko O; Ogita S
Fertil Steril; 2001 Jan; 75(1):125-30. PubMed ID: 11163826
[TBL] [Abstract][Full Text] [Related]
24. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
[TBL] [Abstract][Full Text] [Related]
25. Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.
Nakayama M; Mitsuhashi T; Shimizu Y; Ishihara O; Shimizu M
Pathol Int; 2008 May; 58(5):268-74. PubMed ID: 18429824
[TBL] [Abstract][Full Text] [Related]
26. Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3.
Joseph DS; Malik M; Nurudeen S; Catherino WH
Fertil Steril; 2010 Mar; 93(5):1500-8. PubMed ID: 19328471
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
28. Oestrogen deficiency causes DNA damage in uterine leiomyoma cells: a possible mechanism for shrinkage of fibroids by GnRH agonists.
Cheng YM; Chou CY; Huang SC; Lin HC
BJOG; 2001 Jan; 108(1):95-102. PubMed ID: 11213012
[TBL] [Abstract][Full Text] [Related]
29. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
[TBL] [Abstract][Full Text] [Related]
30. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
Ding L; Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of insulin-like growth factor type I receptor and uterine volume changes in gonadotropin-releasing hormone analog-treated uterine leiomyomas.
Di Lieto A; Iannotti F; De Falco M; Staibano S; Pollio F; Ciociola F; De Rosa G
Am J Obstet Gynecol; 2003 Mar; 188(3):702-6. PubMed ID: 12634644
[TBL] [Abstract][Full Text] [Related]
32. Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas.
Palomba S; Orio F; Falbo A; Oppedisano R; Tolino A; Zullo F
Fertil Steril; 2008 Jul; 90(1):165-73. PubMed ID: 18001721
[TBL] [Abstract][Full Text] [Related]
33. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
[TBL] [Abstract][Full Text] [Related]
34. Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.
Gueye NA; Mead TJ; Koch CD; Biscotti CV; Falcone T; Apte SS
J Clin Endocrinol Metab; 2017 May; 102(5):1631-1641. PubMed ID: 28323982
[TBL] [Abstract][Full Text] [Related]
35. Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells.
Greco S; Islam MS; Zannotti A; Delli Carpini G; Giannubilo SR; Ciavattini A; Petraglia F; Ciarmela P
Reprod Biomed Online; 2020 Apr; 40(4):593-602. PubMed ID: 32276890
[TBL] [Abstract][Full Text] [Related]
36. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
Mizutani T; Sugihara A; Nakamuro K; Terada N
J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
[TBL] [Abstract][Full Text] [Related]
37. Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens.
Hansen LM; Batzer FR; Corson SL; Bello S
J Reprod Med; 1997 Apr; 42(4):247-50. PubMed ID: 9131500
[TBL] [Abstract][Full Text] [Related]
38. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women.
Malik M; Norian J; McCarthy-Keith D; Britten J; Catherino WH
Semin Reprod Med; 2010 May; 28(3):169-79. PubMed ID: 20414841
[TBL] [Abstract][Full Text] [Related]
39. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
Stovall TG; Ling FW; Henry LC; Woodruff MR
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]